In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster session 3: Chronic heart failure
Session

Congress : Heart Failure 2017

Topic : Miscellaneous

  • Session type : Poster Session
  • Date : 01 May 2017
  • Time : 08:30 - 18:00

78 presentations in this session

Clinical features of patients with heart failure with very reduced ejection fraction (hfvref)

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : EJJ Chuquiure (Mexico City,MX)

Time trends in the use and appropriateness of natriuretic peptide testing in primary care

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : FH Rutten (Utrecht,NL)

Severe retinal endothelial dysfunction in patients with ischemic cardiomyopathy

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : J Barthelmes (Zurich,CH)

LCZ696 compassionate use progamme at mater dei hospital, malta

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : LL Buttigieg (Attard,MT)

Comparison of ischemic and non-ischemic heart failure outpatients in a Turkish cohort

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : C Altin (Izmir,TR)

Quality of life predicts exercise capacity in heart failure patients

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : A Ahmeti (Prishtine,XK)

Safety and effectiveness of sacubitril/valsartan in real-life practice

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : J Berger (Cote Saint Luc,CA)

Ivabradine and heart failure: experience from a real practice

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : L Mircheva (Varna,BG)

Mapping heart failure: patient-level costs of an integrated care pathway

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : M Ledwidge (Dun Laoghaire,IE)

Are our heart failure patients with preserved ejection fraction ready to be included in trials?

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : B Neves (Lisboa,PT)

Personalized approach to heart failure with preserved ejection fraction (HFpEF), the Maastricht experience

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : A Barandiaran (Maastricht,NL)

Heart failure specialist versus general cardiologist in the management of chronic heart failure in Russia

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : M Sitnikova (St-Petersburg,RU)

Left ventricular assistance device for destination therapy: results in the west region of France

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : P Teruin (Nantes,FR)

NT pro BNP - a decision factor in preventing heart failure at diabetic patients

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : I Dimitriu (Bucharest,RO)

Pending heart failure clinic opening: care performance measures in real-life practice

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : S Villevalde (Moscow,RU)

The difference between drug usage in patients with HFrEF and HFmrEF: results from TREAT HF

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : A Celik (Mersin,TR)

Impact of Ivabradine to improve the heart rate variability in patients with chronic heart failure

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : K Hristova (Sofia,BG)

Safety of sacubitril/valsartan in patients receiving statins in the PARADIGM-HF trial

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : B Balas (Basel,CH)

Achievement of optimal medication doses during the heart failure titration process

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : S O'Leary (Dublin,IE)

Frusemide adjustment in heart failure HF) during ramadhan: effectiveness and safety pilot study.

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : KK Chow (Kota Kinabalu,MY)

Collaboration cardiologists-pharmacists for improving heart failure medication management.

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : M Roubille (Montpellier Cedex 5,FR)

Loop diuretic down-titration in stable chronic heart failure: role for spot urinary chloride analysis?

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : FH Verbrugge (Heusden-Zolder,BE)

Heart failure with recovered ejection fraction: clinical characteristics, determinants and prognosis.

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : RM Agra Bermejo (Teo,ES)

Prognostic value of different cardiohepatic syndrome variants during the chronic heart failure

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : Y Shaposhnikova (Kharkiv,UA)

Validation of the seattle heart failure model (SHFM) in an Iranian heart failure population

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : M Soltani (Yazd,IR)

The prognostic impact of subclinical hypothyroidism in heart failure

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : ML Goncalves (Vila Nova De Famalicao,PT)

Prognostic implication of right and left-sided hemodynamic congestion in patients with heart failure

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : P Rozentryt (Zabrze,PL)

Characteristics of heart failure patients in indonesia

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : B Karim (Jakarta Pusat,ID)

The role of anti-oxidants in the treatment of congestive heart failure

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : T Michailidis (Alexandria,GR)

Heart failure hospitalization: a decade-long trend overview in a Tertiary Care Center

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : G Di Stolfo (San Giovanni Rotondo,IT)

Predictors of non-response to physical rehabilitation in patients with chronic heart failure

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : V Galenko (Saint Petersburg,RU)

Galectin-3, longitudinal strain and left ventricular remodelling in patients with aortic stenosis

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : LN Agoston Vas Coldea (Cluj-Napoca,RO)

Trends of heart failure hospitalization during a large period of eleven years.

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : ML Fernandez Gasso (Jaen,ES)

Xanthine metabolism in patients with chronic heart failure and concomitant chronic kidney disease.

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : A Bilchenko (Kharkov,UA)

Prevalence geriatric syndromes among outpatients with and without chronic heart failure

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : Y Kotovskaya (Moscow,RU)

Heart failure with mid-range ejection fraction - an echocardiographic finding or a clinical phenotype?

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : AD Farcas (Cluj Napoca,RO)

The impact of a specialised community service on heart failure admissions

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : E Chua (London,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are